A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity.
about
Metalloproteinase inhibitors, nonantimicrobial chemically modified tetracyclines, and ilomastat block Bacillus anthracis lethal factor activity in viable cellsChemically modified tetracyclines: The novel host modulating agentsHost modulation therapy: An indispensable part of perioceuticsCardiac matrix: a clue for future therapyA chemically modified tetracycline (CMT-3) is a new antifungal agent.Inhibition of proteolytic, serpinolytic, and progelatinase-b activation activities of periodontopathogens by doxycycline and the non-antimicrobial chemically modified tetracycline derivatives.Caveolin-1 influences vascular protease activity and is a potential stabilizing factor in human atherosclerotic disease.Matrix metalloproteinase inhibitors.Antibiotics for rheumatoid arthritis? Minocycline shows promise in some patients.Matrix metalloproteinase inhibition. From the Jurassic to the third millennium.Tetracyclines for the treatment of rheumatoid arthritis.Doxycycline hydrogels as a potential therapy for ocular vesicant injury.Emergency treatment of chemical and thermal eye burns.Matrix metalloproteinase inhibitors: do they have a place in anticancer therapy?Mediators of periodontal osseous destruction and remodeling: principles and implications for diagnosis and therapy.Intraperitoneal injection of tetracyclines protects mice from lethal endotoxemia downregulating inducible nitric oxide synthase in various organs and cytokine and nitrate secretion in blood.Tetracycline suppresses ATP gamma S-induced CXCL8 and CXCL1 production by the human dermal microvascular endothelial cell-1 (HMEC-1) cell line and primary human dermal microvascular endothelial cellsInter-relationships between rheumatoid arthritis and periodontal disease. A review.The effects of low-level laser therapy on orthodontically induced root resorption.Subantimicrobial dose doxycycline for acne and rosacea.Acute actions and novel targets of matrix metalloproteinases in the heart and vasculatureEmergence of a metalloproteinase / phospholipase A2 axis of systemic inflammation.Current use of anti-infectives in dermatology.Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysmPeriodontitis and rheumatoid arthritis: a review.Implications of diabetes mellitus and periodontal disease.Non-antibacterial tetracycline formulations: clinical applications in dentistry and medicineAntimicrobial or subantimicrobial antibiotic therapy as an adjunct to the nonsurgical periodontal treatment: a meta-analysis.Host-mediated resolution of inflammation in periodontal diseases.Minocycline for short-term neuroprotectionEffectiveness of low-dose doxycycline (LDD) on clinical symptoms of Sjögren's syndrome: a randomized, double-blind, placebo controlled cross-over study.The effects of different tetracyclines on the dentin root surface of instrumented, periodontally involved human teeth: a comparative scanning electron microscope study.A minocycline derivative reduces nerve injury-induced allodynia, LPS-induced prostaglandin E2 microglial production and signaling via toll-like receptors 2 and 4.Effect of systemic matrix metalloproteinase inhibition on periodontal wound repair: a proof of concept trial.The post-NSAID era: what to use now for the pharmacologic treatment of pain and inflammation in osteoarthritis.Biotic acts of antibioticsChanging trends in the clinical course and outcome of bacterial keratitis at King Khaled Eye Specialist Hospital.The post-NSAID era: what to use now for the pharmacologic treatment of pain and inflammation in osteoarthritis.Minocycline: a neuroprotective agent for hypoxic-ischemic brain injury in the neonate?Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix.
P2860
Q24536063-004528FF-8F13-47B2-A14A-1E1BBDAA1C47Q26782549-61DDA847-BDE6-4BF9-8312-C75BE84DF086Q26852306-1146CD81-65FA-4A5B-981D-25200C4E1B9DQ27026864-B88906A1-3E3A-456F-9D49-EFC90BD7D1A1Q30832733-B76C0EB7-EDE3-419D-9094-A4CB5B8F6882Q33183384-EAB61340-6440-4E17-A465-21FE91392693Q33348628-71451EA0-110B-4A3C-BB1C-F9C1C6416652Q33538437-F172C4AB-9497-44B3-989B-38B954C9864CQ33605248-869DD108-E0AB-443F-BEDD-96943922CC4DQ33692943-898277A1-BB45-4310-B603-9050916193F8Q34074938-C3D206E0-11DC-4797-9266-F7F308D9B237Q34206835-E6D5CEDB-1F06-4FC4-850D-FDC024687809Q34572434-3607B5F8-9A02-475E-8D21-AD0B70CD8265Q34687431-EFDE6F04-D9C1-4450-BC1F-F4919AEC33E5Q35024511-B4C0A9FB-DA07-45CD-A48B-8920A04A207AQ35131293-385635A5-53E2-452F-8D21-6A72CF6611ACQ35140699-5A3168E5-0B72-402E-B75D-775EFFB0D95DQ35212215-31760D59-8E61-48A1-B902-012F79BBE26CQ35551450-92E41B58-D09B-409E-8B95-5FE703D265C3Q35606925-6873A4FC-33E7-4F08-B9CB-DCA93A2A8416Q35995215-1B4C5F50-AEBD-46D4-A54B-CB3136E2AFA0Q36176901-5CF12720-5323-4618-BAE4-89F1A3A7C034Q36233506-BF498407-B666-4622-BEE3-B0C175234E10Q36248775-C83B3316-8A73-4FBA-A59A-0438E0287C6AQ36309246-DF0297FD-9CB2-4AFB-99D1-3389C4C4D874Q36312055-2B5F9358-4D33-4AD8-B06C-A05412458810Q36317523-0A87510F-0882-4A58-AC0E-19093586F7EDQ36361191-09B398FC-EEC3-4A19-A946-F6B9C994EC6FQ36362712-BB14531E-13B9-42D5-B551-DACFC8B3A70AQ36428406-C181F07A-C7A0-4B8A-B9B0-968DCE9E67FEQ36449495-A6982968-8AB1-455C-9C13-27E75C72342CQ36881277-993BCB19-781E-401C-AA35-3E01F98163C4Q36917936-F20B2C2E-9475-4814-B8FF-1D3B215CE1BEQ36976237-2A34E52C-599D-42A1-B782-0C1AE893D8ACQ37049693-FD438E33-2C0B-412E-8C18-3862E4675B3FQ37101851-79D47D7E-187D-4D21-8813-0F36B67B2A38Q37127324-BB35780E-0022-4648-984A-C330A1034DE6Q37154872-09A190C4-7E3D-4F78-9C0B-85E547B9AA1EQ37284934-ED0AF53E-BCD1-48EC-8A40-D6326C8B9AA1Q37573155-95ABF7B1-C34E-4640-B266-D766D4032F5F
P2860
A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
A non-antibacterial chemically ...... ammalian collagenase activity.
@en
type
label
A non-antibacterial chemically ...... ammalian collagenase activity.
@en
prefLabel
A non-antibacterial chemically ...... ammalian collagenase activity.
@en
P2093
P1476
A non-antibacterial chemically ...... ammalian collagenase activity.
@en
P2093
G D'Angelo
N S Ramamurthy
R A Greenwald
T F McNamara
P304
P356
10.1177/00220345870660080401
P407
P577
1987-08-01T00:00:00Z